MedTrace Logo

PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon

NCT02854228 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1300

Last updated 2016-08-03

No results posted yet for this study

Summary

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity through computerized collection of comprehensive demographic, therapeutic, pathologic and outcome information on patients harboring pituitary mass lesions of all types.

Conditions

  • Pituitary Tumor

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Principal Investigators

  • Gerald Raverot, MD PhD · Hospices Civils de Lyon

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2015-12-31
Completion
2020-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02854228 on ClinicalTrials.gov